Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 164

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

An Evaluation of the Impact of Apheresis Platelets Used in the Setting of Massively Transfused Trauma Patients

Perkins, Jeremy G., Andrew, Cap P., Spinella, Philip C., Blackbourne, Lorne H., Grathwohl, Kurt W., Repine, Thomas B., Ketchum, Lloyd, Waterman, Paige, Lee, Ruth E., Beekley, Alec C., Sebesta, James A., Shorr, Andrew F., Wade, Charles E., Holcomb, John B.·2009·Journal of Trauma: Injury, Infection & Critical Care

Abstract

INTRODUCTION: Trauma is a major cause of morbidity and mortality worldwide. Of patients arriving to trauma centers, patients requiring massive transfusion (MT, >or=10 units in 24 hours) are a small patient subset but are at the highest risk of mortality. Transfusion of appropriate ratios of blood products to such patients has recently been an area of interest to both the civilian and military medical community. Plasma is increasingly recognized as a critical component, though less is known about appropriate ratios of platelets. Combat casualties managed at the busiest combat hospital in Iraq provided an opportunity to examine this question. METHODS: In-patient records for 8,618 trauma casualties treated at the military hospital in Baghdad more than a 3-year interval between January 2004 and December 2006 were retrospectively reviewed and patients requiring MT (n = 694) were identified. Patients who required MT in the first 24 hours and did not receive fresh whole blood were divided into study groups defined by source of platelets: (1) patient receiving a low ratio of platelets (<1:16 apheresis platelets per stored red cell unit, aPLT:RBC) (n = 214), (2) patients receiving a medium ratio of platelets (1:16 to <1:8 aPLT:RBC) (n = 154), and (3) patients receiving a high ratio of platelets (>or=1:8 aPLT:RBC) (n = 96). The primary endpoint was survival at 24 hours and at 30 days. RESULTS: At 24 hours, patients receiving a high ratio of platelets had higher survival (95%) as compared with patients receiving a medium ratio (87%) and patients receiving the lowest ratio of platelets (64%) (log-rank p = 0.04 and p < 0.001, respectively). The survival benefit for the high and medium ratio groups remained at 30 days as compared with those receiving the lowest ratio of platelets (75% and 60% vs. 43%, p < 0.001 for both comparisons). On multivariate regression, plasma:RBC ratios and aPLT:RBC were both independently associated with improved survival at 24 hours and at 30 days. CONCLUSION: Transfusion of a ratio of >or=1:8 aPLT:RBC is associated with improved survival at 24 hours and at 30 days in combat casualties requiring a MT within 24 hours of injury. Although prospective study is needed to confirm this finding, MT protocols outside of investigational research should consider incorporation of appropriate ratios of both plasma and platelets.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/ta.0b013e31819d8936

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 164

Metadata

Authors
Perkins, J. G., Andrew, C. P., Spinella, P. C., Blackbourne, L. H., Grathwohl, K. W., Repine, T. B., Ketchum, L., Waterman, P., Lee, R. E., Beekley, A. C., Sebesta, J. A., Shorr, A. F., Wade, C. E., & Holcomb, J. B.
Venue
Journal of Trauma: Injury, Infection & Critical Care
Published
2009-04
Volume
66
Issue
4
Pages
S77-S85
ISSN
0022-5282 (ISSN-L)
OpenAlex
W2060354703
Cited by
164
References
1
FWCI
10.59
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An Evaluation of the Impact of Apheresis Platelets Used in the Setting of Massively Transfused Trauma Patients. https://app.cochat.ai/papers/10.1097/ta.0b013e31819d8936
The paper
Perkins, J. G., Andrew, C. P., Spinella, P. C., Blackbourne, L. H., Grathwohl, K. W., Repine, T. B., Ketchum, L., Waterman, P., Lee, R. E., Beekley, A. C., Sebesta, J. A., Shorr, A. F., Wade, C. E., & Holcomb, J. B. (2009). An Evaluation of the Impact of Apheresis Platelets Used in the Setting of Massively Transfused Trauma Patients. Journal of Trauma: Injury, Infection & Critical Care. https://doi.org/10.1097/ta.0b013e31819d8936

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.